Clinical trial
A Single and Multiple Dose Pharmacokinetic Study of Perampanel in Chinese Healthy Subjects
NCT03424564 is registered in ClinicalTrials.gov with Eisai Co., Ltd. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Single and Multiple Dose Pharmacokinetic Study of Perampanel in Chinese Healthy Subjects
- Lead sponsor
- Eisai Co., Ltd.
- Phase
- Phase 1
- Overall status
- Completed
- Start date
- March 20, 2018
- Completion date
- May 25, 2018
- Enrollment
- 44 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
healthy subjects